Has the 5-year survival of patients with malignant hypertension improved over the past 40 years with modern antihypertensive therapy?
Five-year survival for malignant hypertension has significantly improved over the past 40 years, likely due to better blood pressure management and newer medications.
Demography and number of new cases of MHT have not changed dramatically over the past 40 years. Five-year post-MHT survival has improved significantly, possibly related to lower BP targets, tighter BP control, and availability of new classes of antihypertensive drugs.
Lane et al. (Thu,) studied this question.